Back

Doxorubicin-induced cardiomyopathy: gene variant TRPC6 as therapeutic target

26 May 2019 (15:30 - 15:45)
Organised by:
Congress Presentation Part of: Young Investigator Award - Basic Science and Translational Science Cardio-Oncology HFA Premium Access Heart Failure 2019

About the speaker

Photo
Doctor Katelyn Bruno

Mayo Clinic, Jacksonville (United States of America)

5 More presentations in this session

Presentation thumbnail
GRK2 regulates the endothelial responsiveness to bradykinin: role in human angioedema
Doctor J. Gambardella (Napoly, IT)
Abstract Slides Video
Presentation thumbnail
Empaglifozin has cardioprotective and anti-inflammatory effects in mice during doxorubicin treatment
Doctor V. Quagliariello (Naples, IT)
Abstract Slides Video
Presentation thumbnail
Sterol metabolism is differentially regulated in human induced pluripotent stem cell-derived cardiomyocytes of peripartum cardiomyopathy patients
Mr M. Hoes (Maastricht, NL)
Abstract Slides Video
Presentation thumbnail
Gut microbiota composition and interactions with diet: dysbiosis in heart failure is partly related to lower fiber intake
Ms C. Mayerhofer (Oslo, NO)
Abstract
Presentation thumbnail
Diastolic function modulation via protein kinase G-dependent Ca2(+)/calmodulin-dependent protein kinase-II phosphorylation and oxidation
Ms M. Herwig (Bochum, DE)
Abstract

Access the full session

Session thumbnail
Young Investigator Award - Basic Science and Translational Science

The Event

Event poster

Heart Failure 2019

26 May 2019 15:30 CET
You may be interested in
thumbnail
Congress Presentation
Administration of doxorubicin increases the sensitivity of the mitochondrial permeability transition pore to calcium and causes pathological changes in the electrocardiography.
21 May 2023
thumbnail
Congress Presentation
Effect of vitamin D receptor genetic polymorphism on the clinical response to angiotensin converting enzyme inhibitors therapy among breast cancer patients with chemotherapy induced cardiomyopathy
28 August 2023
thumbnail
Webinar
Exercise, rehabilitation and preventive strategies in cardio-oncology
3 December 2025
thumbnail
Congress Presentation
New target for chemotherapy-induced cardiac dysfunction
20 June 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources